Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 6/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | AURKA | O14965 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.43 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.43 |
| ▸ | XBP1 | P17861 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7985844 | 0.94 | GAA (0.52) | GAAHPGDALDH1A1TP53RXFP1 | |
| SCHEMBL7991542 | 0.91 | GAA (0.50) | GAAHPGDALDH1A1TP53RXFP1 | |
| SCHEMBL7974583 | 0.91 | GAA (0.59) | GAAHPGDALDH1A1TP53RXFP1 | |
| SCHEMBL7985575 | 0.90 | HPGD (0.49) | GAAHPGDTP53RXFP1AURKA | |
| SCHEMBL7991871 | 0.90 | GAA (0.51) | GAAHPGDALDH1A1TP53RXFP1 | |
| SCHEMBL7974016 | 0.89 | GAA (0.56) | GAAHPGDALDH1A1TP53RXFP1 | |
| SCHEMBL7985650 | 0.89 | GAA (0.49) | GAAHPGDPOLBTP53RXFP1 | |
| SCHEMBL7974266 | 0.88 | ALDH1A1 (0.50) | GAAHPGDALDH1A1POLBTP53 | |
| SCHEMBL7984692 | 0.88 | GAA (0.48) | GAAHPGDALDH1A1TP53RXFP1 | |
| SCHEMBL7974092 | 0.88 | GAA (0.51) | GAAHPGDALDH1A1TP53RXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6310070-B1 | FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS | JAPAN ENERGY CORPORATION (JP) | 2001-10-30 | — | — | US | disclosed |
| EP-0999211-A1 | NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF | JAPAN ENERGY CORPORATION (JP) | 2000-05-10 | — | — | EP | disclosed |